Robert Markham — Endo Lab

article 1989

Serum CA‐125 Levels m Women with Endometriosis

The Australian & New Zealand journal of obstetrics & gynaecology ·doi:10.1111/j.1479-828x.1989.tb01779.x

Forty-two women with laparoscopically-confirmed pelvic endometriosis (assessed according to the American Fertility Society modified classification) had serum levels of the cell-surface antigen CA-125 measured before, during and after medica…

article 1986

Measured menstrual blood loss in women with menorrhagia associated with pelvic disease or coagulation disorder.

Obstetrics and gynecology

Fifty-five women with a convincing clinical history of menorrhagia associated with recognizable pelvic disease (40 women) or a confirmed coagulation disorder (15 women) were studied through one or more cycles with measurements of menstrual …

article 1982

Dynamic tests of hypothalamic and pituitary function in women treated with danazol

·doi:10.1016/s0015-0282(16)46152-2

Gonadotropin-releasing hormone (GnRH) tests (12 women) and estradiol benzoate stimulation tests (8 women) were carried out before and during short- or long-term treatment with danazol. There was no difference in the height or timing of lute…

article 1982

Influence of danazol treatment during the luteal phase on pituitary and ovarian function during the subsequent menstrual cycle

·doi:10.1016/s0015-0282(16)46153-4

Eight subjects with normal menstrual cycles were treated with danazol (800 mg daily) during one luteal phase to assess the effect on follicular development in the subsequent cycle. Plasma levels of luteinizing hormone (LH), follicle-stimula…

article 1981

Efficacy of mefenamic acid in patients with a complaint of menorrhagia.

Sixty-nine patients with a convincing history of menorrhagia completed a 4-cycle double-blind randomized placebo-controlled crossover trial of mefenamic acid taken during menstruation. Only 30 of these patients demonstrated objective menorr…